Pharma Consumer Goods Environmental Academia
SOLVO Biotechnology: The Transporter Company - We get you through barriers!
Custom Services: Fee-For-Service Screening Home

Fee-For-Service Screening


Dear Customer,

In a response to the rapidly increasing popularity of our screening services we have developed a new client focused process. The first step of this process is to make sure that from the very beginning of the project we align your screening needs with the various service packages that we offer.

This insures that we deliver on your screening objectives in a fast, reliable and focused manner. In order to achieve this, we have created this on line form to help us better understand your screening needs and objectives straight from the start.

So please take a few minutes to register and fill this form detailing your screening requirements! Once you have sent this form on line, you will receive an email confirmation of your request. A member of the Solvo Business Development team will then get in touch with you shortly to discuss the details of the project.

Thank you for using our form!

Fee-For-Service Screening Request Form

We recommend this type of service for customers who would like to test a limited number of compounds (typically <20) more thoroughly by directly utilizing Solvo Biotechnology in vitro testing experience. Typically these assays are performed on compounds in lead optimization or at a later stage, in drug development (preclinical or clinical). We are ready to handle larger compound sets too, however, for large scale screening we suggest to establish these assays in house. We have great expertise in assisting our customers in adapting these assays for in house applications.

ABC Transporter interaction testing might help to understand the mechanism behind the ambiguous ADME/Tox profile of certain drug candidates.

In our lab, we can perform all the ABC transporter measurements listed on our Membrane Preparations page:

A. ABC (efflux) Transporter Assays

1. ATPase Assays [ATPase activation + inhibition]

Transporter

Membrane used

Reference substrate

Positive control

activation / inhibition

Short description

MDR1 / PgP (ABCB1)

SB-MDR1-Sf9-ATPase

Verapamil

Digoxin / Cyclosporine A

Short Description

rat Mdr1b

SB-ratMdr1b-Sf9-ATPase

Verapamil

Quinidine / Cyclosporine A

Short Description

rat Mdr1a

Under development

MRP1 (ABCC1)

SB-MRP1-Sf9-ATPase

NEM-GS

Indomethacin / Benzbromarone

Short Description

MRP2 (ABCC2)

SB-MRP2-Sf9-ATPase

Probenecid

Sulfasalazine / Benzbromarone

Short Description

rat Mrp2

SB-ratMrp2-Sf9-ATPase

Probenecid

Sulfasalazine / Benzbromarone

Short Description

MRP3 (ABCC3)

SB-MRP3-Sf9-ATPase

Benzbromarone

E217βG / Cyclosporine A

Short Description

BCRP (ABCG2)

SB-BRCP-M-ATPase or
SB-BCRPHAM-Sf9-ATPase

Sulfasalazine, Hoechst 33342, KO143

Topotecan / KO143

Short Description

BCRP / MXR – R482G1 (ABCG2-R482G)

SB-BCRP-R482G-Sf9-ATPase

Prazosin, Hoechst 33342, KO143

Mitoxanthron / KO143

Short Description

Substrate / inhibitor used: test drug or test drug + posCTRL

Deliverables: EC50, IC50

Suggested concentration range of test drug: 137 nM – 300 µM

1 Mutant variant (not wild type)

2. Vesicular Transport Assays

Transporter

Membrane used

Reference (reporter) substrate used

Positive control

Short description

MRP1 (ABCC1)

SB-MRP1-Sf9-VT

3H-LTC4 or radioactive form of test drug (TD)

MK571

Short Description

MRP2 (ABCC2)

SB-MRP2-Sf9-VT

3H-E217βG or radioactive form of TD

Benzbromarone

Short Description

MRP3 (ABCC3)

SB-MRP3-Sf9-VT

3H-E217βG or radioactive form of TD

Benzbromarone

Short Description

MRP5 (ABCC5)

SB-MRP5-HEK293-VT

3H-cGMP (1 µM)

Benzbromarone

Short Description

MRP6 (ABCC6)

Under development

BCRP / MXR (ABCG2)

SB-BCRP-M-VT

3H-Estrone-3-sulfate or radioactive form of TD

Methotrexate

Short Description

BCRP / MXR (ABCG2)

SB-BCRP-HAM-Sf9-VT

3H-Estrone-3-sulfate or 3H-Methotrexate

Methotrexate

Short Description

BCRP / MXR (ABCG2)

SB-BCRP-Sf9-VT

3H-Methotrexate or radioactive form of TD

Estrone-3-sulfate

Short Description

mouse BCRP

Under development

BSEP (ABCB11)

SB-BSEP-Sf9-VT

3H-Taurocholate or radioactive form of TD

Cyclosporin A

Short Description

mouse BSEP

SB-mouseBSEP-Sf9-VT

3H-Taurocholate

Cyclosporine A

Short Description

rat BSEP

Under development

ABCA1, ABCG5/G8

Under development

Deliverables: IC50 – for interacting compounds

(Follow-up studies are available, which provide kinetic data: Km, Ki and Vmax)

Concentration range of test drug: 0.41 µM – 300 µM

3. Dye Transport Assays

Transporter

Cell line used

Dye used

Positive control

Short description

MDR1 / PgP (ABCB1)

HL60-MDR or K562-MDR

Calcein AM

Verapamil

Short Description

MRP1 (ABCC1)

HL60-MRP

Calcein AM

MK571

Short Description

MXR / BCRP (ABCG2)

MXR-M

Hoechst 33342

Propietary

Short Description

Deliverables: IC50

Suggested concentration range of test drug: 0,07 µM – 150 µM

4. Nucleotide Trapping

Available for MDR1, MRP1, MRP2, rat Mrp2, MXR and MDR2 (MDR3). Costs are individually based.



B. Uptake Transporter Assays


TransporterReporter substrateReference inhibitorCell typeNegative control
OATP1B1
(SLCO1B1)
3H-Estrone-3-Sulfate Cerivastatin CHOParental cells
OATP1B3
(SLCO1B3)
Fluo-3 Fluvastatin CHOParental cells
OATP2B1
(SLCO2B1)
3H-Estrone-3-Sulfate Fluvastatin MDCKIIParental cells
rat Oatp1a1
(Slco1a1)
3H-Estrone-3-Sulfate Ketoconazole CHOParental cells
NTCP
(SLC10A1)
3H-Taurocholate Taurochenodeoxycholate CHONa+ free buffer
rNtcp
(Slc10a1)
3H-Taurocholate Taurochenodeoxycholate CHONa+ free buffer
PEPT1
(SLC15A1)
Gly-Sar Tyr-Phe CHOParental cells
PEPT2
(SLC15A2)
Gly-Sar Cefadroxil CHOParental cells
PEPT2
(SLC15A2)
Gly-Sar Cefadroxil CHOParental cells
PEPT2
(SLC15A2)
Gly-SarCefadroxilCHOParental cells
OAT13H-p-Aminohippuric acid (PAH) BenzbromaroneCHOParental cells
OCT114C-Tetraethylammonium-chloride (TEA)VerapamilCHOParental cells


C. Monolayer Assays

Monolayer systems consist of a tight cell layer grown on a porous support to separate two fluid compartments. They are widely regarded as the most sophisticated in vitro tools for medium to high throughput modelling of important pharmacokinetic barriers, such as intestinal epithelium, blood-brain barrier etc (see Hamilton RD et al. 2007. for a recent application).
Two systems that are applied widely in monolayer studies are the human colon carcinoma cell line Caco-2 and transfectant MDCKII cells. SOLVO offers several options for both systems.

Caco2 screening services:

      1. Passive permeability studies
      2. Specific transporter studies
      3. Drug-Drug Interaction studies


SOLVO offers a number of standard setups for the above listed studies, which differ in the amount of information derived and costs.
√ Basic - Studies at one concentration
√ Extended - Studies at several concentrations, more controls
√ FDA Guidelines - Studies according to FDA draft guidance (2006)

These standard packages can be customized to suite your needs.

MDCKII screening services:

Cell lineApplicationPositive controlNegative control
MDCKII-BCRPDirect BCRP interactionTransport of PrazosinParental cell line
 Inhibition of prazosin transportKo134NA
MDCKII-mBcrp1Direct mBcrp1 interactionTransport of PrazosinParental cell line
 nhibition of prazosin transportKo134NA
MDCKII-
OATP2B1/BCRP
Direct vectorial transportEstrone-3-Sulfate transportParental cell line
and BCRP,
OATP2B1 single
transfectants
 Inhibition of Estrone-3-Sulfate transportEstrone and Ko134NA
MDCKII-NTCP/BSEPUnder development
LLC-PK1-MDR1Under development

D. Other Assays

SOLVO development pipelin also includes the following elements: Vectorial assays, Physiological Barrier Models, Toxicity Microarray, Transporter chip, Transporter humanized knock-out and knock-in animals. Different new assays are under development for several other human and animal ABC efflux and uptake transporters.

General Remarks

Screening results are usually available within 4 to 10 weeks. The schedule might depend on the actual workload of SOLVO’s laboratory. We can provide a final schedule before contracting, including needed quantity of test drugs. Performing inhibition and activation assays is always strongly recommended.

Assays are carried out in duplicates. Upon request of customer, assays can be carried out in triplicates. Positive controls are also available.

We provide a detailed report at the end of each task, including a guide for conclusions.

PRICES ARE AVAILABLE UPON REQUEST.
Additional volume based discounts are also available!

 

Home
 
Last updated: January 14, 2008
This page contains information about following topics: Pgp, P-gp, MDR1, ABCB1, P-glycoprotein, MRP1, ABCC2, MRP2, ABCC2, cMOAT, MRP3, ABCC3, cMOAT-2, MRP4, ABCC4, MOATB, MRP5, ABCC6, BCRP, MXR, ABCG2, BSEP, ABCB11, ratBsep, mouse bsep, mouse bcrp, mouse mxr, rat Mdr, rat Mrp2, MDR3, NTCP, SLC10A1, rat Ntcp, OATP1B1, OATP-C, OATP2, SLCO1B1, OATP1B3, OATP8, SLCO1B3, OATP2B1, OATP-B, SLCO2B1, rat Oatp1a1, Oatp1, rat Oatp1a4, Oatp2, rat Oatp1b2, Oatp4, PEPT1, SLC15A1, PEPT2, SLC15B2membrane transporter,calcein assay kit,screening,MDR1,MRP1,MRP2,MRP3,MRP4,MXR,BSEP,blood-brain barrier, Dubin-Johnson, bilirubin, efflux transport, organic anion transport, hepatobiliary secretion, kidney secretion.